These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 16650196

  • 21. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C, Chan AT, Tramontano AC, Gazelle GS.
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [Abstract] [Full Text] [Related]

  • 22. [Problems of cardiovascular toxicity of coxibs and non-selective NSA].
    Forejtová S.
    Vnitr Lek; 2006 Jun; 52(7-8):677-85. PubMed ID: 16967608
    [Abstract] [Full Text] [Related]

  • 23. Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.
    Tacconelli S, Bruno A, Grande R, Ballerini P, Patrignani P.
    Expert Opin Drug Saf; 2017 Jul; 16(7):791-807. PubMed ID: 28569569
    [Abstract] [Full Text] [Related]

  • 24. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ, Benraad HB, Rasker JJ.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1062-7. PubMed ID: 17552414
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor.
    Mukherjee D.
    Thromb Haemost; 2006 Oct 12; 96(4):407-12. PubMed ID: 17003915
    [Abstract] [Full Text] [Related]

  • 27. The murky waters of the coxibs: a review of the current state of play.
    Ostor AJ, Hazleman BL.
    Inflammopharmacology; 2005 Oct 12; 13(4):371-80. PubMed ID: 16354390
    [Abstract] [Full Text] [Related]

  • 28. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
    Aneja A, Farkouh ME.
    Ther Adv Cardiovasc Dis; 2008 Feb 12; 2(1):53-66. PubMed ID: 19124408
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cardiovascular effects of cyclooxygenase-2 inhibitors.
    Brophy JM.
    Curr Opin Gastroenterol; 2007 Nov 12; 23(6):617-24. PubMed ID: 17906437
    [Abstract] [Full Text] [Related]

  • 32. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M, Burnier M.
    Expert Opin Drug Saf; 2006 Jan 12; 5(1):83-94. PubMed ID: 16370958
    [Abstract] [Full Text] [Related]

  • 33. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
    Whelton A.
    Am J Cardiol; 2006 May 08; 97(9A):3-9. PubMed ID: 16675316
    [Abstract] [Full Text] [Related]

  • 34. What price pain relief?
    Hochman JS, Shah NR.
    Circulation; 2006 Jun 27; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Nonsteroidal anti-inflammatory drugs and the risk of cardiovascular diseases].
    Jukić A, Kaliterna DM, Radić M.
    Reumatizam; 2010 Jun 27; 57(1):26-8. PubMed ID: 20941937
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF, Hsiao FY, Wen YW, Tsai YW.
    Clin Ther; 2006 Nov 27; 28(11):1827-36. PubMed ID: 17213003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.